Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Wyss Institute at Harvard University

Wyss Institute at Harvard University Announces Appointment of Natalie Artzi, Ph.D., to Associate Institute Director
From Wyss Institute at Harvard University
Via GlobeNewswire
Wyss Institute Launches Healthy Aging Fund with a Gift from The Colossal Foundation
From Wyss Institute at Harvard University
Via GlobeNewswire
Wyss Institute Research Collaboration Awarded ARPA-H Agreement to Develop Disease-Agnostic Immunotherapeutic RNA Platform
From Wyss Institute at Harvard University
Via GlobeNewswire
Attivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies
From Wyss Institute at Harvard University
Via GlobeNewswire
Circe Bioscience licenses technology to decarbonize industry with microbes developed at Wyss Institute at Harvard University
From Wyss Institute at Harvard University
Via GlobeNewswire
Wyss Institute’s AminoX project receives funding from Northpond Labs to accelerate innovation in protein-based therapeutics
From Wyss Institute at Harvard University
Via GlobeNewswire
Harvard’s Wyss Institute and Collaborative Fund cofound research lab to fund technology to combat climate change
From Wyss Institute at Harvard University
Via GlobeNewswire
Wyss Institute’s Lab-on-a-Molecule Drug Discovery Project Receives Funding from Northpond Labs
From Wyss Institute at Harvard University
Via GlobeNewswire
Gameto licenses Wyss Institute’s technology for growing human ovaries from Harvard University
From Wyss Institute at Harvard University
Via GlobeNewswire
Wyss Institute at Harvard University partners with Northpond Labs to launch RNA solutions company EnPlusOne Biosciences
From Wyss Institute at Harvard University
Via GlobeNewswire
Sherlock Biosciences licenses Wyss Institute’s ambient nucleic acid amplification technology from Harvard to develop highly accurate, low-cost diagnostics for point-of-need
From Wyss Institute at Harvard University
Via GlobeNewswire
Unravel Biosciences licenses Wyss Institute platform technology from Harvard and Tufts University to decode, model, and treat complex diseases
From Wyss Institute at Harvard University
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.